Correspondencia: Lourdes Girona-Brumós. Área de Traumatología y Rehabilitación. Servicio de Farmacia. Hospital Universitario Vall d’Hebron. Paseo del Valle de Hebron, 119-129. 08035 Barcelona. España.
se ha leído el artículo
array:24 [ "pii" => "S0213911106715783" "issn" => "02139111" "doi" => "10.1157/13086038" "estado" => "S300" "fechaPublicacion" => "2006-03-01" "aid" => "71578" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "copyrightAnyo" => "2006" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Gac Sanit. 2006;20 Supl 1:143-53" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4334 "formatos" => array:3 [ "EPUB" => 136 "HTML" => 3579 "PDF" => 619 ] ] "itemSiguiente" => array:19 [ "pii" => "S0213911106715795" "issn" => "02139111" "doi" => "10.1157/13086039" "estado" => "S300" "fechaPublicacion" => "2006-03-01" "aid" => "71579" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Gac Sanit. 2006;20 Supl 1:154-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4596 "formatos" => array:3 [ "EPUB" => 149 "HTML" => 3758 "PDF" => 689 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Parte III. Recursos asistenciales y utilización</span>" "titulo" => "La distribución y dispensación de medicamentos" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "154" "paginaFinal" => "159" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Pharmaceutical distribution and retail pharmacy" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ricard Meneu" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Ricard" "apellidos" => "Meneu" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911106715795?idApp=WGSE" "url" => "/02139111/00000020000000S1/v1_201301241552/S0213911106715795/v1_201301241552/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0213911106715771" "issn" => "02139111" "doi" => "10.1157/13086037" "estado" => "S300" "fechaPublicacion" => "2006-03-01" "aid" => "71577" "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Gac Sanit. 2006;20 Supl 1:135-42" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3968 "formatos" => array:3 [ "EPUB" => 149 "HTML" => 3281 "PDF" => 538 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Parte III. Recursos asistenciales y utilización</span>" "titulo" => "La atención a la dependencia en España" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "135" "paginaFinal" => "142" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Long-term care services in Spain: an overview" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "David Casado-Marín" "autores" => array:1 [ 0 => array:2 [ "nombre" => "David" "apellidos" => "Casado-Marín" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911106715771?idApp=WGSE" "url" => "/02139111/00000020000000S1/v1_201301241552/S0213911106715771/v1_201301241552/es/main.assets" ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Parte III. Recursos asistenciales y utilización</span>" "titulo" => "Luces y sombras de la prestación farmacéutica en España: a propósito de los antidepresivos y antipsicóticos" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "143" "paginaFinal" => "153" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Lourdes Girona-Brumós, Ramón Ribera-Montañá, Juan Carlos Juárez-Giménez, María Pilar Lalueza-Broto" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Lourdes" "apellidos" => "Girona-Brumós" "email" => array:1 [ 0 => "lgirona@vhebron.net" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff1" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor1" ] ] ] 1 => array:3 [ "nombre" => "Ramón" "apellidos" => "Ribera-Montañá" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff2" ] ] ] 2 => array:3 [ "nombre" => "Juan" "apellidos" => "Carlos Juárez-Giménez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff1" ] ] ] 3 => array:3 [ "nombre" => "María" "apellidos" => "Pilar Lalueza-Broto" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff1" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Farmacia. Área de Traumatología y Rehabilitación. Hospital Universitario Vall d’Hebron. Barcelona. España" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff1" ] 1 => array:3 [ "entidad" => "Servicio de Farmacia. Centros Asistenciales Dr. Emili Mira i López. Santa Coloma de Gramenet. Barcelona. España" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff2" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "⁎" "correspondencia" => "Correspondencia: Lourdes Girona-Brumós. Área de Traumatología y Rehabilitación. Servicio de Farmacia. Hospital Universitario Vall d’Hebron. Paseo del Valle de Hebron, 119-129. 08035 Barcelona. España." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Positive and negative aspects of pharmaceutical services in Spain: about antidepressants and antipsychotics" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec13946" "palabras" => array:7 [ 0 => "Antidepresivos" 1 => "Antipsicóticos" 2 => "Depresión" 3 => "Esquizofrenia" 4 => "Trastorno bipolar" 5 => "Trastornos conductuales del anciano con demencia" 6 => "Evaluación económica" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec13945" "palabras" => array:7 [ 0 => "Antidepressants" 1 => "Antipsychotic" 2 => "Depression" 3 => "Schizophrenia" 4 => "Bipolar disorder" 5 => "Behavioural and psychological symptoms of dementia" 6 => "Economic evaluation" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">Las enfermedades mentales presentan una baja mortalidad pero son altamente discapacitantes, lo que ha hecho que su diagnóstico y tratamiento ocupen un papel cada vez más relevante en la terapia actual y en las políticas sanitarias.</p><p class="elsevierStyleSimplePara elsevierViewall">En este escenario se planteó este estudio, que pretende analizar los factores que pueden haber influido en la utilización de antidepresivos y antipsicóticos en España durante el período 1997-2004.</p><p class="elsevierStyleSimplePara elsevierViewall">Los antidepresivos tricíclicos son los fármacos de referencia para tratar la depresión, pero a su perfil de efectos adversos se ha atribuido una falta de adherencia. La búsqueda de una mejor tolerancia, en un mercado en auge, ha favorecido la síntesis de nuevos antidepresivos y la investigación de nuevas indicaciones. Esto explicaría en buena parte el crecimiento del consumo de este grupo, tanto en unidades como en ventas, que ha pasado de 14,14 a 26,79 millones de envases y de 168,61 a 447,11 millones de euros en valor.</p><p class="elsevierStyleSimplePara elsevierViewall">En el caso de los antipsicóticos su utilización se ha mantenido más o menos estable, pasando de 11,74 a 12,65 millones de envases, pero el aumento de facturación ha sido espectacular: ha pasado de 61,84 a 317,46 millones de euros; la risperidona y la olanzapina son las principales causantes de este incremento. Muchos pacientes tratados con antipsicóticos de primera generación han pasado a ser tratados con estos nuevos antipsicóticos.</p><p class="elsevierStyleSimplePara elsevierViewall">Algunos factores que han contribuido a la situación actual son el mayor número de depresiones diagnosticadas, así como de otras enfermedades mentales, el aumento del número de indicaciones aprobadas y el crecimiento de la población anciana tratada con los nuevos antipsicóticos. Todo ello, junto con el marketing promocional, ha disparado la utilización de los principios activos de más reciente comercialización.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p class="elsevierStyleSimplePara elsevierViewall">Mental disorders mortality rates are low but they are extremely disabling so that the diagnosis and treatment of mental illness is an important task for public health and it is central in current therapy strategies and sanitary policy.</p><p class="elsevierStyleSimplePara elsevierViewall">The aim of this study is to analyse conditions influencing antidepressants and antipsychotics use in Spain from 1997 to 2004.</p><p class="elsevierStyleSimplePara elsevierViewall">Tryciclic antidepressants have been of first-choice in depression treatment for many years but their side effects profile are related to a lack of treatment adherence. Trying to increase tolerance, new antidepressants have been developed and research into new therapeutic uses is being done. These are some of the reasons causing an increase in medical utilization and costs. Medical boxes sold have increased from 14,14 million in 1997 to 26,76 million in 2004, meaning 168,61 and 447,11 million euros respectively.</p><p class="elsevierStyleSimplePara elsevierViewall">Antipsychotic use has been maintained, 11,74 million boxes in 1997 and 12,65 in 2004; however, there has been a rise in price from 61,84 to 317,46 million euros due to second generation antipsychotics prescription (mainly risperidone and olanzapine)</p><p class="elsevierStyleSimplePara elsevierViewall">Some conditions have contributed to current situation: increased number of diagnosed patients with depression and other mental disorders, new approved therapeutic uses and a rise in elderly people receiving new antipsychotic agents. Moreover, promotional marketing is causing an increase in new recently commercialised drugs use.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:45 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Organización Mundial de la Salud. [Accedido 14 de Mayo 2004]. Disponible en: <a class="elsevierStyleInterRef" href="http://www.who.int/es/">http://www.who.int/es/</a>" ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Depresión: una prioridad en salud pública" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.L. Ayuso Mateos" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2004" "volumen" => "123" "paginaInicial" => "181" "paginaFinal" => "186" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Género y salud mental en un mundo cambiante" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "I. Montero" 1 => "D. Aparicio" 2 => "M. Gomez-Beneyto" 3 => "B. Moreno-Kustner" 4 => "B. Reneses" 5 => "J. Usall" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Gac Sanit" "fecha" => "2004" "volumen" => "18" "numero" => "Suppl 1" "paginaInicial" => "175" "paginaFinal" => "181" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15171876" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Community mental Health survey in Cantabria: a general description of morbidity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Vázquez-Barquero" 1 => "J.F. Díez-Manrique" 2 => "C. Pena" 3 => "J. Aldama" 4 => "C. Samaniego Rodriguez" 5 => "V. Menéndez Arango" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Psychol Med" "fecha" => "1987" "volumen" => "17" "paginaInicial" => "227" "paginaFinal" => "241" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3495013" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Crossnational epidemiology of major depression and bipolar disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.M. Weissman" 1 => "R.C. Bland" 2 => "G.J. Canino" 3 => "C. Faravelli" 4 => "S. Greenwald" 5 => "H.G. Hwu" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "1996" "volumen" => "276" "paginaInicial" => "293" "paginaFinal" => "299" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8656541" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "La mitad de los depresivos pueden ser en realidad enfermos bipolares" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M. Castillo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "El Correo Farmacéutico" "fecha" => "2005" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiología de los trastornos mentales" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.D. Byrke" 1 => "D.A. Regier" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:2 [ "titulo" => "Tratado de Psiquiatría" "serieFecha" => "1996" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Jablensky" 1 => "N. Sartorius" 2 => "G. Ernberg" 3 => "M. Anker" 4 => "A. Korten" 5 => "J.E. Cooper" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Psychol Med Monogr Supl" "fecha" => "1992" "volumen" => "20" "paginaInicial" => "1" "paginaFinal" => "97" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review of newer pharmacotherapies for depresion in adults: evidence report summary" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.W. Williams" 1 => "C.D. Mulrow" 2 => "E. Chiquette" 3 => "P.H. Noël" 4 => "C. Aguilar" 5 => "J.A. Cornell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2000" "volumen" => "132" "paginaInicial" => "743" "paginaFinal" => "756" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10787370" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Problems with currently available antidepressants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.F. Gumnick" 1 => "C.N. Nemeroff" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Clin Psychiatry" "fecha" => "2000" "volumen" => "61" "numero" => "Suppl 10" "paginaInicial" => "5" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11154018" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "How should efficacy be evaluated in randomized clinical trials of treatments for depression?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.E. Thase" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Clin Psychiatry" "fecha" => "1999" "volumen" => "60" "numero" => "Suppl 4" "paginaInicial" => "23" "paginaFinal" => "31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10634352" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Eficacia y seguridad de la asociación de antidepresivos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. De la Gándara" 1 => "L. Agüera" 2 => "F. Ferre" 3 => "E. Rojo" 4 => "S. Ros" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Actas Esp Psiquiat" "fecha" => "2002" "volumen" => "30" "paginaInicial" => "75" "paginaFinal" => "84" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical guidelines for the treatment of depresive didorders. IV: Medications and other biological treatments" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.H. Kennedy" 1 => "R.W. Lam" 2 => "N.L. Cohen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Can J Psychiatry" "fecha" => "2001" "volumen" => "46" "numero" => "Suppl 1" "paginaInicial" => "38" "paginaFinal" => "58" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Protocolos terapéuticos de la depression aguda y crónica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "N. Cardoner" 1 => "M.E. Lorán" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Medicine" "fecha" => "2003" "volumen" => "8" "paginaInicial" => "5679" "paginaFinal" => "5684" ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Discontinuing or switching selective serotonine-reuptake inhibitors" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.A. Bull" 1 => "E.M. Hunkeler" 2 => "J.Y. Lee" 3 => "C.R. Rowland" 4 => "T.E. Williamson" 5 => "J.R. Schwab" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann Pharmacother" "fecha" => "2002" "volumen" => "36" "paginaInicial" => "578" "paginaFinal" => "584" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11918502" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Agencia Española de Medicamentos y Productos Sanitarios. Nota informativa Ref: 2004/06, de 29 de junio de 2004. Uso de medicamentos Inhibidores Selectivos de la Recaptación de Serotonina en el tratamiento de Trastornos Depresivos en niños y adolescentes. Disponible en: <a class="elsevierStyleInterRef" href="http://www.agemed.es/actividad/alertas/usoHumano/seguridad/serotonina.htm">http://www.agemed.es/actividad/alertas/usoHumano/seguridad/serotonina.htm</a>" ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.J. Whittington" 1 => "T. Kendall" 2 => "P. Fonagy" 3 => "D. Cottrell" 4 => "A. Cotgrove" 5 => "E. Boddington" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(04)16043-1" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2004" "volumen" => "363" "paginaInicial" => "1341" "paginaFinal" => "1345" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15110490" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Drugdex<span class="elsevierStyleSup">®</span> Editorial Staff. Micromedex<span class="elsevierStyleSup">®</span> Healthcare Series. Vol. 124 exp 6/2005. [Accedido 31 Mayo 2005]. Disponible en: <a class="elsevierStyleInterRef" href="http://www.cofb.net/">http://www.cofb.net</a>" ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B.H. Mulsant" 1 => "G.S. Alexopoulos" 2 => "C.F. Reynolds" 3 => "I.R. Katz" 4 => "R. Abrams" 5 => "D. Oslin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Geriatr Psychiatry" "fecha" => "2001" "volumen" => "16" "paginaInicial" => "585" "paginaFinal" => "592" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11424167" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Un isomère du citalopram, sans aucun avantage thérapeutique" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "Anónimo. Escitalopram" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Prescrire" "fecha" => "2004" "volumen" => "24" "paginaInicial" => "325" "paginaFinal" => "328" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consideraciones sobre el tratamiento farmacológico de los trastornos depresivos: De los inhibidores de la recaptación de serotonina a la reboxetina" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Ribera" 1 => "J.C. Juárez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "El Farmacéutico Hospitales" "fecha" => "2004" "volumen" => "156" "paginaInicial" => "36" "paginaFinal" => "43" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "El futuro de la farmacoterapia en la esquizofrenia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.M. Kane" 1 => "A. Malhotra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "World Psychiatry (ed. esp.)" "fecha" => "2003" "volumen" => "1" "paginaInicial" => "81" "paginaFinal" => "86" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regresion analisis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Geddes" 1 => "N. Freemantle" 2 => "P. Harrison" 3 => "P. Bebbington" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BMJ" "fecha" => "2000" "volumen" => "321" "paginaInicial" => "1371" "paginaFinal" => "1376" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11099280" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New generation antipsychotics versus low potency conventional antipsychotics: a systematic review and metaanalysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S. Leutcht" 1 => "K. Wahlbeck" 2 => "J. Hamann" 3 => "W. Kissling" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(03)13306-5" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2003" "volumen" => "361" "paginaInicial" => "1581" "paginaFinal" => "1589" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12747876" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A meta-analysis of the efficacy of second-generation antipsychotics" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.M. Davis" 1 => "N. Chen" 2 => "I.D. Glirck" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Gen Psichiatry" "fecha" => "2003" "volumen" => "60" "paginaInicial" => "553" "paginaFinal" => "564" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effectiveness and cost of olanzapine and haloperidol in the treatment of shizophrenia: a randomized controlled trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Rosenheck" 1 => "O. Perlick" 2 => "S. Bingham" 3 => "W. Liu Mares" 4 => "J. Collins" 5 => "S. Warren" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.290.20.2693" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2003" "volumen" => "290" "paginaInicial" => "2693" "paginaFinal" => "2702" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14645311" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Choosing the right dose of antipsychotics in schizophrenia. Lessons from neuroimaging studies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J. Tauscher" 1 => "J. Kafur" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "CNS Drugs" "fecha" => "2001" "volumen" => "15" "paginaInicial" => "671" "paginaFinal" => "678" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11580306" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recent studies on the neurocognitiev effects of second-generation antipsychotic medication" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.E. Green" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Curr Opin Psychiatry" "fecha" => "2002" "volumen" => "15" "paginaInicial" => "25" "paginaFinal" => "29" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antipsicóticos atípicos: una nueva etiología en la diabetes mellitus tipo 2" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L. Flores" 1 => "A. Sanmartí" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2005" "volumen" => "124" "paginaInicial" => "341" "paginaFinal" => "343" ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib30" "etiqueta" => "30." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clozapine in prevention of suicide in patients with schizophrenia or schizoaffective disorder" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.J. Wagstaff" 1 => "C.M. Perry" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "CNS Drug" "fecha" => "2003" "volumen" => "17" "paginaInicial" => "273" "paginaFinal" => "280" ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib31" "etiqueta" => "31." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Anónimo. Drugs for disruptive features in dementia. DTB. 2003;41:1-8." ] ] ] 31 => array:3 [ "identificador" => "bib32" "etiqueta" => "32." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Caro I, Ribera R, Pascual B, Ayestarán A, Aguas M. Utilización de fármacos antipsicóticos en pacientes geriátricos. Comunicación póster. XLVI Congreso de la Sociedad Española de Geriatría y Gerontología. Las Palmas de Gran Canaria, 9-12 de junio de 2004." ] ] ] 32 => array:3 [ "identificador" => "bib33" "etiqueta" => "33." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.E. Lee" 1 => "S.S. Gill" 2 => "M. Freedman" 3 => "S.E. Bronskill" 4 => "M.P. Hillmer" 5 => "P.A. Rochon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.38125.465579.55" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2004" "volumen" => "329" "paginaInicial" => "75" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15194601" "web" => "Medline" ] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib34" "etiqueta" => "34." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Agencia Española de Medicamentos y Productos Sanitarios. Nota informativa Ref: 2004/03, de 9 de marzo de 2004. Nuevos datos de seguridad sobre los antipsicóticos Olanzapina y Risperidona en el tratamiento de pacientes ancianos con psicosis o trastornos de conducta asociados a demencia. Disponible en: <a class="elsevierStyleInterRef" href="http://www.agemed.es/actividad/alertas/usoHumano/seguridad/serotonina.htm">http://www.agemed.es/actividad/alertas/usoHumano/seguridad/serotonina.htm</a>" ] ] ] 34 => array:3 [ "identificador" => "bib35" "etiqueta" => "35." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Agencia Española de Medicamentos y Productos Sanitarios. Nota informativa Ref: 2004/04, de 10 de mayo de 2004. Risperidona: Riesgo de episodios isquémicos cerebrales en pacientes con demencia. Restricción de las condiciones de uso. Disponible en: <a class="elsevierStyleInterRef" href="http://www.agemed.es/actividad/alertas/usoHumano/seguridad/serotonina.htm">http://www.agemed.es/actividad/alertas/usoHumano/seguridad/serotonina.htm</a>" ] ] ] 35 => array:3 [ "identificador" => "bib36" "etiqueta" => "36." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Depresión y guías de práctica clínica: ¿evidencia o confusión?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.D. Navarro-Rubio" 1 => "N. Giménez" 2 => "A. Casasa" 3 => "M. Piro Ibáñez" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "2000" "volumen" => "114" "numero" => "Supl 2" "paginaInicial" => "52" "paginaFinal" => "56" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib37" "etiqueta" => "37." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Do therapeutic indications of antidepressants change from one year to another?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. De las Cuevas" 1 => "E. Sanz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/pds.891" "Revista" => array:6 [ "tituloSerie" => "Pharmacoepidemiol Drug Saf" "fecha" => "2004" "volumen" => "13" "paginaInicial" => "309" "paginaFinal" => "314" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15133783" "web" => "Medline" ] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib38" "etiqueta" => "38." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Revisión de los antidepresivos en el tratamiento del trastorno de ansiedad generalizada" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Hoenh-Saric" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:2 [ "titulo" => "La neurosis de angustia en el siglo XXI" "serieFecha" => "2004" ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib39" "etiqueta" => "39." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evolución del consumo de antidepresivos en España. Impacto de los inhibidores selectivos de la recaptación de serotonina" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.P. Alonso" 1 => "F.J. Abajo" 2 => "J.J. Martínez" 3 => "D. Montero" 4 => "G. Martín-Serrano" 5 => "M. Madurga" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Med Clin (Barc)" "fecha" => "1997" "volumen" => "108" "paginaInicial" => "161" "paginaFinal" => "166" ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib40" "etiqueta" => "40." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: Systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Mac Gillivray" 1 => "B. Arroll" 2 => "S. Hatcher" 3 => "S. Ogstan" 4 => "I. Reid" 5 => "F. Sullivan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.326.7397.1014" "Revista" => array:5 [ "tituloSerie" => "BMJ" "fecha" => "2003" "volumen" => "326" "paginaInicial" => "1014" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12742924" "web" => "Medline" ] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib41" "etiqueta" => "41." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Centorrino" 1 => "J.L. Goren" 2 => "J. Hennen" 3 => "P. Salvatore" 4 => "J.P. Kelleher" 5 => "R.J. Baldessarini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1176/appi.ajp.161.4.700" "Revista" => array:6 [ "tituloSerie" => "Am J Psychiatry" "fecha" => "2004" "volumen" => "161" "paginaInicial" => "700" "paginaFinal" => "706" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15056517" "web" => "Medline" ] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib42" "etiqueta" => "42." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Randomized controlled trails in schizophrenia: a critical perspective on the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Gilbody" 1 => "K. Wahlbeck" 2 => "C. Adams" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Acta Psychiatrr Scan" "fecha" => "2002" "volumen" => "105" "paginaInicial" => "243" "paginaFinal" => "251" ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib43" "etiqueta" => "43." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tratamiento psicofarmacológico de la esquizofrenia. Cerebro y Salud mental" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "A. Huidobro Pérez-Villamil" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:3 [ "fecha" => "2002" "editorial" => "Ed. Mapfre" "editorialLocalizacion" => "Madrid" ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib44" "etiqueta" => "44." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Le coût de la maladie: un labyrinthe inextricable ou une aide à la décision?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Launois" 1 => "M. Toumi" 2 => "J. Reboul-Marty" 3 => "C. Lançon" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Le cas de la schizophrénie. L’Encéphale" "fecha" => "1998" "volumen" => "XXIV" "paginaInicial" => "83" "paginaFinal" => "89" ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib45" "etiqueta" => "45." "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Anónimo. Grupos terapéuticos y Principios activos de mayor consumo en el Sistema Nacional de Salud durante 2003. Información Terapéutica del Sistema Nacional de Salud. 2004;25:121-4." ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02139111/00000020000000S1/v1_201301241552/S0213911106715783/v1_201301241552/es/main.assets" "Apartado" => array:4 [ "identificador" => "745" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Parte III. Recursos asistenciales y utilización" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02139111/00000020000000S1/v1_201301241552/S0213911106715783/v1_201301241552/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911106715783?idApp=WGSE" ]
Idioma original: Español
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 4 | 1 | 5 |
2024 Octubre | 64 | 48 | 112 |
2024 Septiembre | 54 | 26 | 80 |
2024 Agosto | 71 | 43 | 114 |
2024 Julio | 50 | 26 | 76 |
2024 Junio | 39 | 27 | 66 |
2024 Mayo | 44 | 35 | 79 |
2024 Abril | 41 | 22 | 63 |
2024 Marzo | 37 | 22 | 59 |
2024 Febrero | 36 | 38 | 74 |
2024 Enero | 34 | 21 | 55 |
2023 Diciembre | 28 | 17 | 45 |
2023 Noviembre | 34 | 23 | 57 |
2023 Octubre | 34 | 30 | 64 |
2023 Septiembre | 35 | 20 | 55 |
2023 Agosto | 37 | 11 | 48 |
2023 Julio | 42 | 33 | 75 |
2023 Junio | 36 | 16 | 52 |
2023 Mayo | 19 | 17 | 36 |